Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Oliver Langer

Showing results (61-70 of 160) with videos related to

Pageof 16
Sort By:
Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism|June 15, 2019
Measurement of cerebral ABCC1 transport activity in wild-type and APP/PS1-21 mice with positron emission tomographyViktoria Zoufal, Severin Mairinger, Markus Krohn, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|April 15, 2020
Assessing the Activity of Multidrug Resistance-Associated Protein 1 at the Lung Epithelial BarrierSeverin Mairinger, Johannes A Sake, Irene Hernández Lozano, et al.
Antimicrobial Agents and Chemotherapy|September 25, 2004
[18F]Ciprofloxacin, a new positron emission tomography tracer for noninvasive assessment of the tissue distribution and pharmacokinetics of ciprofloxacin in humansMartin Brunner, Oliver Langer, Georg Dobrozemsky, et al.
European Journal of Nuclear Medicine and Molecular Imaging|February 7, 2025
Effect of probenecid on the whole-body disposition of 6-bromo-7-[<sup>11</sup>C]methylpurine in humans assessed with long axial field-of-view PET/CTMatthias Jackwerth, Severin Mairinger, Ivo Rausch, et al.
EJNMMI Radiopharmacy and Chemistry|June 12, 2018
Comparison of fully-automated radiosyntheses of [<sup>11</sup>C]erlotinib for preclinical and clinical use starting from in target produced [<sup>11</sup>C]CO<sub>2</sub> or [<sup>11</sup>C]CH<sub>4</sub>Cécile Philippe, Severin Mairinger, Verena Pichler, et al.
EJNMMI Radiopharmacy and Chemistry|April 29, 2024
Advancing 6-bromo-7-[<sup>11</sup>C]methylpurine to clinical use: improved regioselective radiosynthesis, non-clinical toxicity data and human dosimetry estimatesSeverin Mairinger, Matthias Jackwerth, Ondřej Soukup, et al.
Drug Delivery and Translational Research|January 3, 2018
Intravenous infusion for the controlled exposure to the dual ABCB1 and ABCG2 inhibitor elacridar in nonhuman primatesSébastien Goutal, Oliver Langer, Sylvain Auvity, et al.
Pharmaceutics|May 31, 2020
Validation of Pharmacological Protocols for Targeted Inhibition of Canalicular MRP2 Activity in Hepatocytes Using [<sup>99m</sup>Tc]mebrofenin Imaging in RatsSolène Marie, Irene Hernández-Lozano, Louise Breuil, et al.
Nuclear Medicine and Biology|March 12, 2004
Biological evaluation of 2'-[18F]fluoroflumazenil ([18F]FFMZ), a potential GABA receptor ligand for PETMarkus Mitterhauser, Wolfgang Wadsak, Leila Wabnegger, et al.
Molecular Pharmaceutics|October 26, 2023
Dissimilar Effect of P-Glycoprotein and Breast Cancer Resistance Protein Inhibition on the Distribution of Erlotinib to the Retina and Brain in Humans and MiceMyriam El Biali, Sylvain Auvity, Salvatore Cisternino, et al.
Pageof 16

Showing results (61-70 of 160) with videos related to

Sort By:
Pageof 16
Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism|June 15, 2019
Measurement of cerebral ABCC1 transport activity in wild-type and APP/PS1-21 mice with positron emission tomographyViktoria Zoufal, Severin Mairinger, Markus Krohn, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|April 15, 2020
Assessing the Activity of Multidrug Resistance-Associated Protein 1 at the Lung Epithelial BarrierSeverin Mairinger, Johannes A Sake, Irene Hernández Lozano, et al.
Antimicrobial Agents and Chemotherapy|September 25, 2004
[18F]Ciprofloxacin, a new positron emission tomography tracer for noninvasive assessment of the tissue distribution and pharmacokinetics of ciprofloxacin in humansMartin Brunner, Oliver Langer, Georg Dobrozemsky, et al.
European Journal of Nuclear Medicine and Molecular Imaging|February 7, 2025
Effect of probenecid on the whole-body disposition of 6-bromo-7-[<sup>11</sup>C]methylpurine in humans assessed with long axial field-of-view PET/CTMatthias Jackwerth, Severin Mairinger, Ivo Rausch, et al.
EJNMMI Radiopharmacy and Chemistry|June 12, 2018
Comparison of fully-automated radiosyntheses of [<sup>11</sup>C]erlotinib for preclinical and clinical use starting from in target produced [<sup>11</sup>C]CO<sub>2</sub> or [<sup>11</sup>C]CH<sub>4</sub>Cécile Philippe, Severin Mairinger, Verena Pichler, et al.
EJNMMI Radiopharmacy and Chemistry|April 29, 2024
Advancing 6-bromo-7-[<sup>11</sup>C]methylpurine to clinical use: improved regioselective radiosynthesis, non-clinical toxicity data and human dosimetry estimatesSeverin Mairinger, Matthias Jackwerth, Ondřej Soukup, et al.
Drug Delivery and Translational Research|January 3, 2018
Intravenous infusion for the controlled exposure to the dual ABCB1 and ABCG2 inhibitor elacridar in nonhuman primatesSébastien Goutal, Oliver Langer, Sylvain Auvity, et al.
Pharmaceutics|May 31, 2020
Validation of Pharmacological Protocols for Targeted Inhibition of Canalicular MRP2 Activity in Hepatocytes Using [<sup>99m</sup>Tc]mebrofenin Imaging in RatsSolène Marie, Irene Hernández-Lozano, Louise Breuil, et al.
Nuclear Medicine and Biology|March 12, 2004
Biological evaluation of 2'-[18F]fluoroflumazenil ([18F]FFMZ), a potential GABA receptor ligand for PETMarkus Mitterhauser, Wolfgang Wadsak, Leila Wabnegger, et al.
Molecular Pharmaceutics|October 26, 2023
Dissimilar Effect of P-Glycoprotein and Breast Cancer Resistance Protein Inhibition on the Distribution of Erlotinib to the Retina and Brain in Humans and MiceMyriam El Biali, Sylvain Auvity, Salvatore Cisternino, et al.
Pageof 16